Expression of a human P-450IIC gene in yeast cells using galactose-inducible expression system.

PubWeight™: 0.94‹?›

🔗 View Article (PMID 2649791)

Published in Mol Pharmacol on April 01, 1989

Authors

T Yasumori1, N Murayama, Y Yamazoe, A Abe, Y Nogi, T Fukasawa, R Kato

Author Affiliations

1: Department of Pharmacology, School of Medicine, Keio University, Tokyo, Japan.

Articles by these authors

The genetic system controlling homothallism in Saccharomyces yeasts. Genetics (1974) 4.20

Interaction of super-repressible and dominant constitutive mutations for the synthesis of galactose pathway enzymes in Saccharomyces cerevisiae. Mol Gen Genet (1977) 4.14

Real-time detection system for quantification of hepatitis C virus genome. Gastroenterology (1999) 3.83

Dentatorubral and pallidoluysian atrophy expansion of an unstable CAG trinucleotide on chromosome 12p. Nat Genet (1994) 3.17

Infection with hepatitis GB virus C in patients on maintenance hemodialysis. N Engl J Med (1996) 3.13

Spred is a Sprouty-related suppressor of Ras signalling. Nature (2001) 2.87

Identification of Grf1 on mouse chromosome 9 as an imprinted gene by RLGS-M. Nat Genet (1996) 2.77

Regulation of expression of the galactose gene cluster in Saccharomyces cerevisiae. Isolation and characterization of the regulatory gene GAL4. Mol Gen Genet (1983) 2.66

Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin? J Invest Dermatol (1991) 2.52

GAL11 protein, an auxiliary transcription activator for genes encoding galactose-metabolizing enzymes in Saccharomyces cerevisiae. Mol Cell Biol (1988) 2.41

The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2. J Biol Chem (2001) 2.29

Enteropathogenic Escherichia coli protein secretion is induced in response to conditions similar to those in the gastrointestinal tract. Infect Immun (1997) 2.23

Supermolecular structure of the enteropathogenic Escherichia coli type III secretion system and its direct interaction with the EspA-sheath-like structure. Proc Natl Acad Sci U S A (2001) 2.21

Multiprotein transcription factor UAF interacts with the upstream element of the yeast RNA polymerase I promoter and forms a stable preinitiation complex. Genes Dev (1996) 2.19

The cortical representation of speech. J Cogn Neurosci (1993) 2.12

Enterohemorrhagic Escherichia coli O157:H7 produces Tir, which is translocated to the host cell membrane but is not tyrosine phosphorylated. Infect Immun (1999) 2.04

Primary structure of the Saccharomyces cerevisiae GAL7 gene. Yeast (1985) 2.02

RRN3 gene of Saccharomyces cerevisiae encodes an essential RNA polymerase I transcription factor which interacts with the polymerase independently of DNA template. EMBO J (1996) 1.97

Nucleotide sequence of the yeast regulatory gene GAL80. Nucleic Acids Res (1984) 1.91

Control of segregation of chromosomal DNA by sex factor F in Escherichia coli. Mutants of DNA gyrase subunit A suppress letD (ccdB) product growth inhibition. J Mol Biol (1992) 1.91

The pathogenesis of experimental membranous glomerulonephritis induced with homologous nephritogenic tubular antigen. J Exp Med (1976) 1.87

RRN6 and RRN7 encode subunits of a multiprotein complex essential for the initiation of rDNA transcription by RNA polymerase I in Saccharomyces cerevisiae. Genes Dev (1994) 1.82

Correlation of tissue and plasma RANTES levels with disease course in patients with breast or cervical cancer. Clin Cancer Res (2001) 1.79

L-arginine-induced hypotension. Lancet (1990) 1.77

Nucleotide sequence of the transcriptional initiation region of the yeast GAL7 gene. Nucleic Acids Res (1983) 1.77

Structural alterations of the nucleolus in mutants of Saccharomyces cerevisiae defective in RNA polymerase I. Mol Cell Biol (1993) 1.76

Signal sequence for generation of mRNA 3' end in the Saccharomyces cerevisiae GAL7 gene. EMBO J (1990) 1.76

Yeast Gal11 protein mediates the transcriptional activation signal of two different transacting factors, Gal4 and general regulatory factor I/repressor/activator site binding protein 1/translation upstream factor. Proc Natl Acad Sci U S A (1990) 1.74

Improved inhibitors of glucosylceramide synthase. J Biol Chem (1999) 1.72

Duplicate upstream activating sequences in the promoter region of the Saccharomyces cerevisiae GAL7 gene. Mol Cell Biol (1986) 1.66

Galactose-dependent reversible interaction of Gal3p with Gal80p in the induction pathway of Gal4p-activated genes of Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1997) 1.65

JE-2147: a dipeptide protease inhibitor (PI) that potently inhibits multi-PI-resistant HIV-1. Proc Natl Acad Sci U S A (1999) 1.65

Segmented filamentous bacteria prevent colonization of enteropathogenic Escherichia coli O103 in rabbits. J Infect Dis (2000) 1.64

Regulation of expression of the galactose gene cluster in Saccharomyces cerevisiae. II. The isolation and dosage effect of the regulatory gene GAL80. Mol Gen Genet (1984) 1.62

Oceanobacillus iheyensis gen. nov., sp. nov., a deep-sea extremely halotolerant and alkaliphilic species isolated from a depth of 1050 m on the Iheya Ridge. FEMS Microbiol Lett (2001) 1.58

Differential phenotypic expression by three mutant alleles in familial lecithin:cholesterol acyltransferase deficiency. Lancet (1991) 1.56

Analysis of the galactose signal transduction pathway in Saccharomyces cerevisiae: interaction between Gal3p and Gal80p. Mol Cell Biol (1996) 1.51

Anti-tumor promoting action of phthalic acid mono-n-butyl ester cupric salt, a biomimetic superoxide dismutase. Carcinogenesis (1990) 1.49

Mechanisms of Igf2/H19 imprinting: DNA methylation, chromatin and long-distance gene regulation. J Biochem (2000) 1.48

Crystal structure of a repair enzyme of oxidatively damaged DNA, MutM (Fpg), from an extreme thermophile, Thermus thermophilus HB8. EMBO J (2000) 1.48

Role of EspB in experimental human enteropathogenic Escherichia coli infection. Infect Immun (2000) 1.47

L-arginine-induced hypotension. Lancet (1991) 1.47

Inhibition by nitric oxide and nitric oxide-producing vasodilators of DNA synthesis in vascular smooth muscle cells. Eur J Pharmacol (1990) 1.47

Identification of a dominant negative mutant of Sprouty that potentiates fibroblast growth factor- but not epidermal growth factor-induced ERK activation. J Biol Chem (2001) 1.44

[Radiological study of the accessory skeletal elements in the foot and ankle (author's transl)]. Nihon Seikeigeka Gakkai Zasshi (1981) 1.44

Crystal structure of Thermus thermophilus HB8 UvrB protein, a key enzyme of nucleotide excision repair. J Biochem (1999) 1.43

Purification of the N-type calcium channel associated with syntaxin and synaptotagmin. A complex implicated in synaptic vesicle exocytosis. J Biol Chem (1994) 1.43

The health system in Nepal-An introduction. Environ Health Prev Med (2001) 1.41

Controlled transcription of the yeast regulatory gene GAL80. Gene (1985) 1.40

The origin of hypsarrhythmia and tonic spasms in West syndrome: evidence from a case of porencephaly and hydrocephalus with focal hypsarrhythmia. Brain Dev (1999) 1.40

Guidance with real-time CT fluoroscopy: early clinical experience. Radiology (1996) 1.40

Cell cycle arrest induced by an inhibitor of glucosylceramide synthase. Correlation with cyclin-dependent kinases. J Biol Chem (1995) 1.39

Homing, proliferation and survival sites of human leukemia cells in vivo in immunodeficient mice. Leukemia (2006) 1.38

Sex-related differences in drug metabolism. Drug Metab Rev (1974) 1.38

cDNA cloning of the hydroxysteroid sulfotransferase STa sharing a strong homology in amino acid sequence with the senescence marker protein SMP-2 in rat livers. Biochem Biophys Res Commun (1990) 1.37

Transcriptional activation of a ras-like gene (kir) by oncogenic tyrosine kinases. Proc Natl Acad Sci U S A (1994) 1.37

Studies on the mechanism of drug-induced microsomal enzyme activities. V. Phenobarbital stimulation of endogenous messenger RNA and polyuridylic acid-directed L-[14C]-phenylalanine incorporation. Mol Pharmacol (1966) 1.36

Protection against varicella in family contacts by immediate inoculation with live varicella vaccine. Pediatrics (1977) 1.35

Transient changes of serum lipoprotein(a) as an acute phase protein. Atherosclerosis (1989) 1.34

Utilization of bloodfed females of Aedes aegypti as a vehicle for the transfer of the insect growth regulator pyriproxyfen to larval habitats. J Am Mosq Control Assoc (1994) 1.34

Laboratory model of membranous glomerulonephritis in rats induced by pronase-digested homologous renal tubular epithelial antigen. Lab Invest (1975) 1.34

Mechanism of host-controlled restriction of bacteriophage lambda by R factors in Escherichia coli K12. Virology (1968) 1.32

C-kit gene abnormalities in gastrointestinal stromal tumors (tumors of interstitial cells of Cajal. Jpn J Cancer Res (1999) 1.31

Comparative genomic sequencing identifies novel tissue-specific enhancers and sequence elements for methylation-sensitive factors implicated in Igf2/H19 imprinting. Genome Res (2000) 1.30

Role of furanocoumarin derivatives on grapefruit juice-mediated inhibition of human CYP3A activity. Drug Metab Dispos (2000) 1.27

Cancer-associated myofibroblasts possess various factors to promote endometrial tumor progression. Clin Cancer Res (2001) 1.27

Specific inactivation of infectious lambda DNA by sonicates of restrictive bacteria with R factors. Biochem Biophys Res Commun (1966) 1.27

Endothelin-mediated stimulation of DNA synthesis in vascular smooth muscle cells. Biochem Biophys Res Commun (1989) 1.26

Constitutive kinase activation of the TEL-Syk fusion gene in myelodysplastic syndrome with t(9;12)(q22;p12). Blood (2001) 1.25

DNA analysis in hereditary dentatorubral-pallidoluysian atrophy: correlation between CAG repeat length and phenotypic variation and the molecular basis of anticipation. Neurology (1995) 1.24

Embryonic form of smooth muscle myosin heavy chain (SMemb/MHC-B) in gastrointestinal stromal tumor and interstitial cells of Cajal. Am J Pathol (1999) 1.23

Metabolism of drugs in old rats. II. Metabolism in vivo and effect of drugs in old rats. Jpn J Pharmacol (1968) 1.23

Males in rural Bangladeshi communities are more susceptible to chronic arsenic poisoning than females: analyses based on urinary arsenic. Environ Health Perspect (2001) 1.22

Active site of mu-conotoxin GIIIA, a peptide blocker of muscle sodium channels. J Biol Chem (1991) 1.21

TRPV1 activation and induction of nociceptive response by a non-pungent capsaicin-like compound, capsiate. Neuropharmacology (2003) 1.20

The enzymes of the galactose cluster in Saccharomyces cerevisiae. II. Purification and characterization of uridine diphosphoglucose 4-epimerase. J Biol Chem (1980) 1.20

Apolipoprotein(a) kringle IV repeat number predicts risk for coronary heart disease. Arterioscler Thromb Vasc Biol (1996) 1.20

Electrophysiologic effects of the levo- and dextrorotatory isomers of sotalol in isolated cardiac muscle and their in vivo pharmacokinetics. J Am Coll Cardiol (1986) 1.20

Functional domains of a negative regulatory protein, GAL80, of Saccharomyces cerevisiae. Mol Cell Biol (1989) 1.19

Extremely barophilic bacteria isolated from the Mariana Trench, Challenger Deep, at a depth of 11,000 meters. Appl Environ Microbiol (1998) 1.19

Enteropathogenic Escherichia coli: a pathogen that inserts its own receptor into host cells. Cell Mol Life Sci (1999) 1.18

Limit on neutrinoless ββ decay of 136Xe from the first phase of KamLAND-Zen and comparison with the positive claim in 76Ge. Phys Rev Lett (2013) 1.18

Up-regulation of nitric oxide synthase by estradiol in human aortic endothelial cells. FEBS Lett (1995) 1.17

Risk and prevention of graft failure in patients with preexisting donor-specific HLA antibodies undergoing unmanipulated haploidentical SCT. Bone Marrow Transplant (2011) 1.17

Thyroid hormone and activities of drug-metabolizing enzymes and electron transport systems of rat liver microsomes. Mol Pharmacol (1968) 1.16

GAL3 gene product is required for maintenance of the induced state of the GAL cluster genes in Saccharomyces cerevisiae. J Bacteriol (1986) 1.16

Tumor seeding after endoscopic ultrasound-guided fine-needle aspiration of cancer in the body of the pancreas. Endoscopy (2012) 1.16

Interleukin-1 beta augments release of norepinephrine, dopamine, and serotonin in the rat anterior hypothalamus. J Neurosci (1993) 1.16

Predictive factors for intrahepatic recurrence of hepatocellular carcinoma after partial hepatectomy. Cancer (1992) 1.15